Met Life Investment Management, LLC Edgewise Therapeutics, Inc. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 44,612 shares of EWTX stock, worth $1.21 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
44,612
Previous 42,271
5.54%
Holding current value
$1.21 Million
Previous $1.13 Million
5.59%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding EWTX
# of Institutions
215Shares Held
98.3MCall Options Held
885KPut Options Held
232K-
Orbimed Advisors LLC San Diego, CA15MShares$407 Million10.86% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$241 Million3.85% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$167 Million1.82% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$163 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75MShares$135 Million10.85% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.71B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...